rhenium-186 hedp has been researched along with pamidronate in 1 studies
Studies (rhenium-186 hedp) | Trials (rhenium-186 hedp) | Recent Studies (post-2010) (rhenium-186 hedp) | Studies (pamidronate) | Trials (pamidronate) | Recent Studies (post-2010) (pamidronate) |
---|---|---|---|---|---|
75 | 32 | 19 | 2,220 | 368 | 444 |
Protein | Taxonomy | rhenium-186 hedp (IC50) | pamidronate (IC50) |
---|---|---|---|
Farnesyl pyrophosphate synthase | Homo sapiens (human) | 1.0745 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP | 1 |
1 trial(s) available for rhenium-186 hedp and pamidronate
Article | Year |
---|---|
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis].
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium | 2005 |